Company

Science Corporation

Develops retinal prosthesis implants to restore vision in patients with age-related macular degeneration.

Healthcare & Biotech

People

Funding History

Mar 6, 2026Series C

Science Corporation raised $230M in a Series C round, bringing total capital raised to just under $500M. Funds will support commercialization of its retinal prosthesis device in Europe following a successful clinical trial in age-related macular degeneration, and development of next-generation implants with more electrodes.

230M

News

Interviews (2)

Science Corporation raises $230M after retinal implant helps blind patient finish a 300-page novel

6 Mar 2026

Science Corp's Max Hodak on restoring vision with a retinal chip — and the biohybrid brain interface beyond it

13 Nov 2025